Summary: Date:3/02/2009 Length: 00:012:37 Size: 5.77MB Thought Leaders: John Doyle Dr.P.H., Managing Director and Practice Leader, Market Access, Quintiles Consulting, and Geoff Garabedian, Managing Director and Practice Leader, Regulatory, Quintiles Consulting In this episode, Dr. Doyle outlines cost-based evaluation and market-access strategies based on comparative effectiveness and safety research. Then Mr. Garabedian talks about the impact of regulatory globalization, and finally, there is a discussion covering the latest pharmaceutical initiatives from the European Commission, and how these will impact the global healthcare industry. Play P0dcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
